Notice of Closed Meeting, 10082-10083 [2024-02882]
Download as PDF
<![CDATA[
10082
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–011, Assessment of Perceptions
and Effectiveness of Interventions to
Increase MMR Vaccination Among
Children in Close-knit Communities
with Longstanding Vaccine Hesitancy;
and SIP24–013, Understanding the
Potential of Schools in Promoting Nonmandated Childhood Vaccinations.
Date: May 7, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–001, Understanding the Needs of
Ovarian Cancer Survivors; SIP24–002,
Survivorship Care Plans and Mortality
Among Adult Cancer Survivors; and
SIP24–005, How Does Reducing Social
Isolation and Loneliness Impact Health
Indices Among Cancer Survivors?
Date: April 30, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02884 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
lotter on DSK11XQN23PROD with NOTICES1
[FR Doc. 2024–02877 Filed 2–12–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Closed Meeting
Centers for Disease Control and
Prevention
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
VerDate Sep<11>2014
16:57 Feb 12, 2024
Jkt 262001
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
GH24–033, Advancing Public Health
Research in Bangladesh.
Date: April 9, 2024.
Time: 9 a.m.–2 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Global Health Center, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21–9,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02876 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
E:\FR\FM\13FEN1.SGM
13FEN1
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–008, Managing Epilepsy Well
Network (MEW).
Date: May 9, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–003, Cancer Prevention and
Control Research Network (CPCRN).
Date: May 1, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Natalie Brown, M.P.H., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 639–
4601; Email: NBrown3@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02878 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2024–02882 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
VerDate Sep<11>2014
16:57 Feb 12, 2024
Jkt 262001
Submission for Office of Management
and Budget (OMB) Review; Social
Services Block Grant Post-Expenditure
Report, Pre-Expenditure Report, and
Intended Use Plan (OMB #0970–0234)
Office of Community Services,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
10083
Community Services (OCS) is requesting
from OMB a three-year extension of the
Social Services Block Grant (SSBG)
Post-Expenditure Report, PreExpenditure Report, and Intended Use
Plan (OMB #0970–0234). OCS is
proposing to make minor editorial
modifications to some column titles in
the Pre- and Post-Expenditure Reports,
for clarification.
DATES: Comments are due within 30
days of publication. OMB must decide
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having full
consideration if OMB receives it within
30 days of this publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis,
states and territories are required to
submit the following reports: (1) An
Intended Use Plan that provides data
and narrative descriptions related to the
state’s SSBG program. The Intended Use
Plan includes details about the delivery
of SSBG services and the state agency
administering the SSBG Program. ACF
is proposing to expand the currently
approved information collection to
include the collection of states’
Intended Use Plans with a model
format. Recipients are required to
submit their Pre-Expenditure Report no
less than 30 days prior to the start of the
period covered by the report. (2) A PreExpenditure Report demonstrates the
state’s anticipated allocation of SSBG
funding among the 29 pre-defined SSBG
service categories. Historically, states
have submitted this report using the
Post-Expenditure Report Form, and the
associated burden is included in the
currently approved information
collection. Recipients are required to
submit their Intended Use Plan no less
than 30 days prior to the start of the
period covered by the report, together
with the Pre-Expenditure Report. (3) A
Post-Expenditure Report details the
state’s actual use of SSBG funding
among each of the 29 service categories.
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Pages 10082-10083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02882]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business
[[Page 10083]]
Initiatives, Office of the Chief Operating Officer, CDC, pursuant to
Public Law 92-463. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--SIP24-008, Managing Epilepsy Well
Network (MEW).
Date: May 9, 2024.
Time: 10 a.m.-6 p.m., EDT.
Place: Teleconference/Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Catherine Barrett, Ph.D.,
Scientific Review Officer, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Highway, Mailstop S106-3, Atlanta, Georgia
30341-3717. Telephone: (404) 718-7664; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02882 Filed 2-12-24; 8:45 am]
BILLING CODE 4163-18-P
